Recruiting
A Study Comparing LY900014 to Insulin Lispro (Humalog) in Children and Adolescents With Type 1 Diabetes
I8B-MC-ITSB - ClinicalTrials.gov - NCT03740919
The reason for this study is to compare the study drug LY900014 to insulin lispro (Humalog) in children and adolescents with type 1 diabetes (T1D).
How long will I be in the trial?
The study will last about 33 weeks and may include up to 7 office visits and 9 telephone visits.
Recruiting
A Study Comparing LY900014 to Insulin Lispro (Humalog) in Children and Adolescents With Type 1 Diabetes
I8B-MC-ITSB - ClinicalTrials.gov - NCT03740919
The reason for this study is to compare the study drug LY900014 to insulin lispro (Humalog) in children and adolescents with type 1 diabetes (T1D).
How long will I be in the trial?
The study will last about 33 weeks and may include up to 7 office visits and 9 telephone visits.
Key Requirements
Age :
1-17
Sex:
All
Key Requirements
Use the following checklist to help determine if this trial may be a good fit for you. Place a checkmark next to each criteria that you successfully meet.
Age
1-17
Sex
All
Participants must
Pediatric participant (child or teen) must have type 1 diabetes, taking multiple daily insulin injections
Pediatric participant must be taking one of the following long acting insulins for at least the last 90 days: glargine, or detemir or degludec
Pediatric participant must be taking one of the following mealtime insulins for at least the last 90 days: lispro, or aspart or glulisine
Female participant who is having menstrual period must be on birth control if sexually active.
Pediatric participant must have a recent hemoglobin A1C value ≤ 9.9%
Participants must NOT
Pediatric participant must not have had more than 1 emergency room visit or hospital stay for high or low blood sugar within the last 6 months
Trial Summary
Conditions the trial is for
Type 1 Diabetes
What the trial is testing?
LY900014, Insulin Lispro
Could I receive a Placebo?
no
Enrollment Goal
945
Trial Dates
April 2019 - July 2021
Trial Phase
3
Enter your postal code to find the nearest site
Key Requirements
Use the following checklist to help determine if this trial may be a good fit for you. Place a checkmark next to each criteria that you successfully meet.
Age
1-17
Sex
All
Participants must
Pediatric participant (child or teen) must have type 1 diabetes, taking multiple daily insulin injections
Pediatric participant must be taking one of the following long acting insulins for at least the last 90 days: glargine, or detemir or degludec
Pediatric participant must be taking one of the following mealtime insulins for at least the last 90 days: lispro, or aspart or glulisine
Female participant who is having menstrual period must be on birth control if sexually active.
Pediatric participant must have a recent hemoglobin A1C value ≤ 9.9%
Participants must NOT
Pediatric participant must not have had more than 1 emergency room visit or hospital stay for high or low blood sugar within the last 6 months
Trial Summary
Conditions the trial is for
Type 1 Diabetes
What the trial is testing?
LY900014, Insulin Lispro
Could I receive a Placebo?
no
Enrollment Goal
945
Trial Dates
April 2019 - July 2021
Trial Phase
3
Not the right fit? Sign up to receive updates on new Type 1 Diabetes trials.
Trial Locations
Hide locations not currently recruiting
Enter your postal code to see sites near you
Type 1 Diabetes Resources
